2 Stocks Down 28% and 34% to Buy and Hold
These companies' sell-offs may have gone too far.
Major U.S. stock market indexes have been performing strongly this year, with many reaching record highs. However, this surge has largely been driven by technology and artificial intelligence-driven companies. It's relatively easy to find stocks that have been underperforming, and some of these could be good investment opportunities.
This is particularly true for TransMedics Group (NASDAQ:TMDX) and SoFi Technologies (NASDAQ:SOFI), which have each declined by 28% and 34% respectively over the past year. Here are the reasons why these stocks might be worth considering for long-term investment.
TransMedics Group has played a significant role in revolutionizing the field of organ transplants. The company developed the Organ Care System (OCS), a device that maintains the functionality of organs during the process of transplant preparation. Traditional organ storage methods, involving cold preservation, can cause damage to the organs, rendering them unsuitable for transplantation. This issue highlights the importance of the OCS, which could potentially address the ongoing challenge of organ shortages.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.